The concept of “hangry” helps sell candy bars, and it’s a convenient excuse to snap at someone when you’re in a foul mood. But is hangry — being angry when you’re hungry — a real thing? Do people really become more irritable when they want food? “My wife sometimes used to tell me, ‘you’re being…  read on >  read on >

THURSDAY, July 7, 2022 (American Heart Association News) — Documented cocaine and marijuana use among young adults who had strokes rose substantially in recent decades, especially among white men and women, new research suggests. Overall, however, documented substance use among stroke patients was highest among young Black men. The authors of the study, published Thursday…  read on >  read on >

Could ADHD drugs also treat degenerative brain disorders, such as Alzheimer’s disease? British researchers say there is good evidence that some medications used for attention-deficit/hyperactivity disorder (ADHD) — known as noradrenergic drugs — might also help treat key aspects of Alzheimer’s. “Repurposing of established noradrenergic drugs is most likely to offer effective treatment in Alzheimer’s…  read on >  read on >

An array of problems, including overcrowding, led to a surge of COVID-19 cases in California prisons in 2020-2021, a new report details. Preventing outbreaks in the future will require a comprehensive list of fixes, from reducing overcrowding in the state’s 34 adult prisons to improving old buildings. Vaccination drives and methods for rapid detection are…  read on >  read on >

The U.S. COVID-19 vaccination program slashed the coronavirus’ expected death rate by as much as 58%, saving hundreds of thousands of lives during the first two waves of the pandemic, a new study says. Computer models estimate that vaccines prevented 235,000 COVID deaths in the United States between December 2020 and September 2021, blunting the…  read on >  read on >

The U.S. Food and Drug Administration on Tuesday temporarily suspended its ban on e-cigarettes sold by Juul Labs while the company while appeals the agency’s action. The FDA Center for Tobacco Products wrote on Twitter that “the agency has determined that there are scientific issues unique to the Juul application that warrant additional review,” but…  read on >  read on >